(a) by finding megaloblasts within the peripheral blood or in the marrow (b) by therapeutic tests with cyanocobalamin (vitamin B12) or folic acid. The Bone Marrow The megaloblast is not merely an early red cell; it is morphologically abnormal because of deficiency of either cyanocobalamin or folic acid. The abnormality disappears from the marrow within a few days of commencing therapy with the appropriate agent.
The most diagnostic cell is the Erlich megaloblast. This retains an immature finely stippled nucleus even when haemoglobin has appeared in the cytoplasm. Earlier, less mature, megaloblasts may be difficult to distinguish from non-haemoglobinised precursors of the normoblast or macronormoblastic series. Mature, fully haemoglobinised cells with a pyknotic nucleus are less diagnostic than the Erlich megaloblast.
Megaloblasts may occasionally be found in the peripheral blood, especially if smears are made from the buffet coat (white cell-platelet layer) of a centrifuged specimen.
Other characteristics of the marrow in megaloblastic anaemias are its cellularity (although this may be difficult to assess in a smear obtained by marrow puncture), and the presence of abnormal precursors of the neutrophil series-large myelocytes and metamyelocytes.
In the peripheral blood in Addisonian pernicious anaemia the mean cell volume is usually over iOO (Ungley and Campbell, 1949 and unpublished) .
If the cyanocobalamin is not effective a single dose of folic acid may be given. When the reticulocytosis subsides and when the marrow reverts to megaloblastic another single dose of cyanocobalamin may be tried. Sometimes the latter becomes effective after a temporary need for folic acid has been met.
For a patient who is very ill or has severe heart failure, exchange transfusion of packed red blood cells from a pint (580 ml.) of blood may be given.
If there is diarrhoea or malabsorption it is worth sorting out the nature of the deficiency causing the megaloblastic anaemia by giving serial therapeutic tests. Sometimes there is a deficiency of folic acid which is temporary; after a single dose of folic acid the patient may remain well during maintenance therapy with cyanocobalamin. In other cases only folic acid is needed. Patients with permanent achlorhydria or low serum cyanocobalamin values should be treated with cyanocobalamin in addition to folic acid.
Diagnosis of Folic Acid Deficiency
Malabsorption of folic acid may be detected by the method of Girdwood (1956) . First the patient is saturated with folic acid by injected doses. Then oral and injected doses are given on alternate days. If there is malabsorption the amount of folic acid excreted in twenty-four hours is much less after oral than after intra-muscular administration of a similar dose.
This test for the oral: injection ratio is useful for the detection of malabsorption of folic acid. There is not, however, a satisfactory method at present for detecting folic acid deficiency. (Ungley, 1957) .
Addisonian Pernicious Anaemia
The lesion is an atrophy or atrophic gastritis of the corpus region of the stomach. Once the patient has pernicious anaemia the lesion is irreversible. Because of the resulting loss of intrinsic factor the patient is unable to absorb enough cyanocobalamin from foods (except perhaps from whole liver) to maintain health.
Sometimes the presenting symptoms refer to the nervous system, e.g. paraesthesiae, difficulty in walking or even mental changes with alteration in the psychometric behaviour and in the encephelogram. There may be failure of word discrimination (Ungley, I957) . Occasionally there is a scotoma (' blind spot') in the centre of each visual field.
All these manifestations of cyanocobalamin deficiency may occur before there are abnormalities in the blood or marrow although the serum cyanocobalamin values will probably be low. In doubtful cases the gastric juice should be examined for free hydrochloric acid after administration of histamine by injection and alcohol by mouth. The important point, however, is to be prepared for the occurrence of vitamin B12 deficiency from any cause.
Loss of weight is sometimes observed but seldom noticed early.
Sore tongue can be caused by many other deficiencies but can be due solely to lack of cyanocobalamin, even when there is little or no anaemia (Adams, 1957) .
Routes and Agents
Cyanocobalamin should be given by intramuscular injection. It may seem rational to replace the intrinsic factor with a preparation containing this factor and the vitamin. In fact, however, such preparations are expensive, wasteful and inefficient. Even when the blood counts rise fairly quickly, the level of cyanocobalamin in the serum rises slowly.
Injection intramuscularly avoids the 'intestinal barrier' against cyanocobalamin. High serum levels are achieved quickly, and tissue reserves are rapidly restored.
The 
Iron
In Addisonian pernicious anaemia the serum iron in relapse is usually high but falls within a few days after therapy. The mean corpuscular haemoglobin concentration is normal.
In many patients the excess of iron which accumulates in the tissues during relapse is enough to prevent iron deficiency from developing even during the rapid remission induced by therapy with cyanocobalamin. Even if the stores of iron are insufficient for complete remission, giving iron while the marrow is megaloblastic is in my experience without effect on the haemoglobin concentration, probably because it cannot be utilised at this stage. Later, when the rate of increase of red blood cells is stepped up, the mean corpuscular haemoglobin concentration may fall and the serum iron level will be below normal. Then oral iron therapy may be given for a few weeks. It should be discontinued when the mean corpuscular haemoglobin concentration has risen and if the serum iron remains normal without iron therapy. Continuation of iron for long periods may carry the risk of loading the tissues with an excess of iron.
In non-addisonian megaloblastic anaemias, e.g. in pregnancy or sprue, a concurrent deficiency of iron is common and partly accounts for the low mean cell volume often found in these disorders.
Antibiotics
These are not indicated in pernicious anaemia. If given orally they may destroy intestinal microorganisms which have the power to bind intrinsic factor, but the need for this factor still exists unless the cyanocobalamin is given by intramuscular injection (as it should be).
Gastritis and Carcinoma in Addisonian Pernicious Anaemia
Now that most of the manifestations of cyanocobalamin deficiency can be eliminated the greatest danger of pernicious anaemia is the development of carcinomatous changes in the stomach. Carcinoma may arise either in the atrophic corpus region or in the non-atrophic pylorus region.
Every patient with this disorder has gastritis or gastric atrophy and the incidence of carcinoma of the stomach is much higher than in other members of the population. This is true of pernicious anaemia even during remission. Gastric cytology should be examined after washing out the stomach (Henning and Witte, I957; Schade, i957 (Schade, 1957) .
Objects of therapy in pernicious anaemia
To summarise, these are: i. To restore normal haematological findings. Quite small amounts of cyanocobalamin are needed. Doses as small as io0 g. a fortnight may be enough to achieve normal values although doses twenty times as much may be needed to achieve a maximum rate of increase of red blood cells and packed cell volume in I5 days. (Ungley and Campbell, 1949, and Ungley and Campbellunpublished.) 2. To reverse or to arrest neurological, cerebral, visual and auditory manifestations. This requires maximum dosage (Ungley, 1957 Ungley (I933 and 1938) . In Holland, Nieweg (1953) describes two examples due to low protein diets prescribed for renal disorder.
In Great Britain, Wokes (I954) studied cyanocobalamin deficiency in vegans, i.e. persons living on completely vegetarian diets, without even milk, butter, cheese or eggs. One had sub-acute combined degeneration which responded to cyanocobalamin (Badenoch, 1955) . About a dozen had severe mental or nervous symptoms. Sore tongue or paraesthesiae occurred in about a quarter. None had frank megaloblastic anaemia, perhaps because the intake of folic acid was high. Serum cyanocobalamin values were below Ioo yg/ml. in patients who had been more than six years on the diet.
In a woman vegan, whose serum cyanocobalamin levels were low, central scotomata were almost abolished and virtually normal vision was restored by injection of the vitamin (Ungley, 1957) .
Dysphagia at the pharyngo-oesophageal junction, attributed to chronic iron deficiency in a woman, was associated with hypochlorhydria and megaloblastic anaemia, which responded to yeast (Ungley, 1933, fig. 3 ).
Megaloblastic Anaemia associated with the Fish Tapeworm
Few people who harbour the fish tapeworm develop megaloblastic anaemia. If the worm is living high up in the small intestine, it may compete with the host for cyanocobalamin in food. The worm itself is a rich source of cyanocobalamin.
The incidence and chatacter of neurological disorders are similar' to those in pernicious anaemia. Free hydrochloric acid is usually present in the gastric juice. The response to cyanocobalamin or to folic acid varies in different parts of India, perhaps due to dietary differences.
Megaloblastic Anaemia in Children
This is a mixed group. Infants may become anaemic after an infection or from deficiency of folic acid in the milk, which may be breast milk, cows' milk or even goats' milk. The mothers are not always anaemic. The anaemia is often refractory to cyanocobalamin but responds to folic acid.
A similar megaloblastic anaemia was produced experimentally in scorbutic monkeys, which re,-sponded to folic acid. Malabsorption syndromes may be discovered in children of any age with megaloblastic anaemia. The anaemia may respond either to cyanocobalamin or to folic acid.
Megaloblastic anaemia in childhood may be the initial manifestation of Addisonian pernicious anaemia, as in a child whose father had pernicious anaemia (Mollin, Baker and Doniach, 1955) .
Megaloblastic Anaemia of Pregnancy and the Puerperium
In the tropics this is mainly due to chrcnIc dietary deficiency of folic acid or cyanocobalamin. In any country it may be discovered in patients who already have Addisonian pernicious anaemia or idiopathic steatorrhoea, the pregnancy providing an additional strain on already depleted reserves.
But megaloblastic anaemia of pregnancy and the puerperium in non-tropical countries may exist as a separate entity. Dietary deficiency is common but not invariable. There is a seasonal incidence in the winter or spring (Thompson, I957, shaw, 19 57); but some diets are normal and many patients taking grossly inadequate diets do not develop a megaloblastic marrow. Free hydrochloric acid is usually present in the gastric juice, but it may be temporarily absent during pregnancy.
The red cells are not necessarily large;-the mean cell volume may even be below normal and mean cell diameter may also be small. The only certain way to find out is to do a marrow biopsy or to find megaloblasts in the peripheral blood, e.g. by staining the white cell-platelet layer. This is a doubtful alternative, and once treatment has been given the marrow will be useless for diagnosis. The frequency with which megaloblastic anaemia of pregnancy is diagnosed depends on the frequency with which the observer uses marrow puncture.
Most patients in this country respond to folic acid rather than to cyanocobalamin. In Eire and in America, however, many of the patients respond to cyanocobalamin, and the rest to folic acid. If the anaemia is discovered during pregnancy, the response to the therapy may be slow. The remission goes ahead more rapidly in the puerperium. But often the anaemia is not discovered until a few days after the puerperium and very severe relapse may have taken place. Exchange transfusion may be necessary.
The safest remedy is folic acid, but a test for serum cyanocobalamin may be undertaken. Our results, and those of most others, show normal values.
Folic acid may be given parenterally or orally in doses of about 40 mg. a week. Cyanocobalamin,
